Delivery Order SPE2DR25D2007-SPE2DR26FM07M
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,370.66 to AmerisourceBergen Drug Corp for 90 tablets of Gemtesa 75 mg, with delivery to the company's corporate office in Conshohocken, Pennsylvania. This contract was competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of August 15, 2025. The delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $25,148.50 for 90-tablet supplies of Gemtesa 75 mg tablets under a firm fixed-price contract. The award, made on September 15, 2025, with an ultimate completion date of September 16, 2025, represents a competitively awarded, non-set-aside procurement. Performance of this delivery order is based in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $57,339.96 on September 5, 2025, for the supply of Gemtesa 75 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by September 8, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count) on September 24, 2025, with a ceiling value of $15,126.73. This is a firm fixed-price delivery order with no set-aside designation, executed competitively against the vendor's larger indefinite delivery contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 25, 2025. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90 count) valued at $1,634.22, with an ultimate completion date of June 20, 2025. This non-set-aside, competitively awarded delivery order represents a firm fixed price transaction issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical supply will be delivered to the contractor's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $27,577.00 by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed price delivery order, issued on September 15, 2025, with an ultimate completion date of September 16, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,059.94 by the Defense Logistics Agency's Medical Supply Chain on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed price contract represents a competitively awarded, non-set-aside delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00...
- The Defense Logistics Agency awarded a $8,938.51 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Gemtesa 75 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of September 12, 2025. The award will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child contract under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,173.43 by the Defense Logistics Agency's Medical Supply Chain on July 30, 2025. This firm fixed-price contract, with an ultimate completion date of July 31, 2025, represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at approximately $1,665 by the Defense Logistics Agency Troop Support Medical to supply 75mg Gemtesa tablets. The order is to deliver 30 tablets to a location in Conshohocken, Pennsylvania by July 10, 2023, in support of the Defense Logistics Agency's medical supply chain responsibilities. No subcontractors or set aside designations were indicated. The...
- SPE2DR25D2007Indefinite Delivery Contract
- SPE2DR25D2007-SPE2DR26FM07MDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency for Gemtesa 75 mg tablets (30-count units) with a ceiling value of $96,726.89 under a firm fixed-price contract type. The award was made on November 3, 2025, with an ultimate completion date of November 4, 2025, and represents a non-set-aside competitive procurement. The place of performance is located at the contractor's corporate office in Conshohocken, PA. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a prime contract value of $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The firm fixed-price delivery order structure and competitive award designation reflect the contractor's demonstrated capability to meet federal procurement requirements for medical commodities. Through its DLA prime contract vehicle, the company provides pharmaceutical support globally across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard, positioning it as a key supplier within the military healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $96.7k | 11/3/25 |